Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Dyne Therapeutics Inc shares valued at $26,347 were sold by Farwell Wildon on Mar 12 ’24. At $25.58 per share, Farwell Wildon sold 1,030 shares. The insider’s holdings dropped to 150,560 shares worth approximately $3.76 million following the completion of this transaction.
Also, Brumm Joshua T sold 66,387 shares, netting a total of over 1,704,142 in proceeds. Following the sale of shares at $25.67 each, the insider now holds 537,998 shares.
Before that, McNeill Jonathan had sold 19,601 shares from its account. In a trade valued at $499,842, the Chief Business Officer traded Dyne Therapeutics Inc shares for $25.50 each. Upon closing the transaction, the insider’s holdings decreased to 19,601 shares, worth approximately $3.48 million.
As published in their initiating research note from H.C. Wainwright on February 20, 2024, Dyne Therapeutics Inc [DYN] has been a Buy and the price target has been revised to $36. Analysts at Raymond James upgraded the stock from ‘”an Outperform”‘ to ‘”a Strong buy”‘ outlook in a report released in late February. As of February 15, 2023, Oppenheimer has initiated its “an Outperform” rating for DYN. Earlier on January 26, 2023, Guggenheim initiated its rating. Their recommendation was “a Buy” for DYN stock.
Analyzing DYN Stock Performance
During the last five days, there has been a surge of approximately 0.64%. Over the course of the year, Dyne Therapeutics Inc shares have jumped approximately 87.82%. Shares of the company reached a 52-week high of $30.27 on 03/01/24 and a 52-week low of $12.33 on 01/03/24. A 50-day SMA is recorded $25.98, while a 200-day SMA reached $15.43. Nevertheless, trading volume fell to 0.68 million shares from 0.81 million shares the previous day.
Support And Resistance Levels for Dyne Therapeutics Inc (DYN)
According to the 24-hour chart, there is a support level at 24.63, which, if violated, would cause prices to drop to 24.29. In the upper region, resistance lies at 25.62. The next price resistance is at 26.27. RSI (Relative Strength Index) is 45.87 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.50, which suggests the price will decrease in the coming days. Percent R is at 60.13%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
